M. Walshaw

973 total citations
40 papers, 732 citations indexed

About

M. Walshaw is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Emergency Medical Services. According to data from OpenAlex, M. Walshaw has authored 40 papers receiving a total of 732 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 6 papers in Emergency Medical Services. Recurrent topics in M. Walshaw's work include Cystic Fibrosis Research Advances (15 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Pediatric health and respiratory diseases (4 papers). M. Walshaw is often cited by papers focused on Cystic Fibrosis Research Advances (15 papers), Lung Cancer Diagnosis and Treatment (5 papers) and Pediatric health and respiratory diseases (4 papers). M. Walshaw collaborates with scholars based in United Kingdom and United States. M. Walshaw's co-authors include C.C. Evans, C R Hind, T. G. MERRETT, E. B. Mitchell, Peter Howarth, Matthew J. Colloff, Ashley Woodcock, J. O. Warner, J G Ayres and F. Carswell and has published in prestigious journals such as Thorax, European Journal of Cancer and Clinical & Experimental Allergy.

In The Last Decade

M. Walshaw

35 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Walshaw United Kingdom 9 329 327 307 110 92 40 732
Jordan N. Fink United States 10 131 0.4× 350 1.1× 195 0.6× 136 1.2× 41 0.4× 13 757
Jim Mark Ingram United States 8 352 1.1× 548 1.7× 814 2.7× 82 0.7× 226 2.5× 11 1.1k
A J Woolcock Australia 13 957 2.9× 694 2.1× 1.4k 4.5× 188 1.7× 175 1.9× 15 1.8k
Hugo Van Bever Singapore 15 102 0.3× 290 0.9× 302 1.0× 212 1.9× 31 0.3× 33 622
F. Brémont France 10 240 0.7× 243 0.7× 149 0.5× 134 1.2× 49 0.5× 61 607
L. G. Hansen Denmark 14 117 0.4× 608 1.9× 429 1.4× 173 1.6× 53 0.6× 19 934
George W. Ward United States 12 135 0.4× 152 0.5× 162 0.5× 32 0.3× 62 0.7× 17 431
Garrison H. Ayars United States 13 226 0.7× 140 0.4× 339 1.1× 31 0.3× 76 0.8× 20 700
Paraskevi Xepapadaki Greece 22 485 1.5× 299 0.9× 653 2.1× 124 1.1× 43 0.5× 76 1.4k
Marina Attanasi Italy 13 233 0.7× 96 0.3× 203 0.7× 73 0.7× 11 0.1× 70 574

Countries citing papers authored by M. Walshaw

Since Specialization
Citations

This map shows the geographic impact of M. Walshaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Walshaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Walshaw more than expected).

Fields of papers citing papers by M. Walshaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Walshaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Walshaw. The network helps show where M. Walshaw may publish in the future.

Co-authorship network of co-authors of M. Walshaw

This figure shows the co-authorship network connecting the top 25 collaborators of M. Walshaw. A scholar is included among the top collaborators of M. Walshaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Walshaw. M. Walshaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burnett, Simon, et al.. (2021). P094 Facilitating cystic fibrosis research during the COVID-19 pandemic. Journal of Cystic Fibrosis. 20. S68–S68.
2.
3.
Nazareth, D., et al.. (2021). Managing an adult CF population in the COVID-19 pandemic—1 year on. QJM. 115(8). 521–524.
4.
5.
Frost, Freddy, M. Walshaw, & D. Nazareth. (2020). Cystic fibrosis-related diabetes: an update. QJM. 115(9). 582–585. 5 indexed citations
6.
Frost, Freddy, Joanne L. Fothergill, Craig Winstanley, M. Walshaw, & D. Nazareth. (2020). P150 Aztreonam lysine recovers lung function and improves quality of life in the treatment of acute exacerbations of cystic fibrosis: results from an open-label randomised crossover study (AZTEC-CF). Journal of Cystic Fibrosis. 19. S98–S98. 6 indexed citations
7.
Whitty, C. W. M., et al.. (2019). P121 Levofloxacin inhaled solution; a retrospective tolerability study. Journal of Cystic Fibrosis. 18. S91–S92.
8.
Jackson, V. Margaret, et al.. (2017). 294 Exploring the utility of continuous glucose monitoring (CGMS) for cystic fibrosis related diabetes (CFRD). Journal of Cystic Fibrosis. 16. S137–S137. 2 indexed citations
9.
Nazareth, D., et al.. (2016). P254 Validation of telemedicine spirometry. Thorax. 71(Suppl 3). A225–A226.
10.
Smyth, C., et al.. (2015). S76 “Straight to CT” in Primary Care – Improving the Lung Cancer Patient Journey. Thorax. 70(Suppl 3). A45.1–A45. 1 indexed citations
11.
Frost, Freddy, et al.. (2014). P78 Can Pet Standard Uptake Variable (suv) Predict Disease Progression In Early-stage Non-small Cell Lung Cancer (nsclc)?. Thorax. 69(Suppl 2). A110–A110. 1 indexed citations
12.
Holemans, John A., et al.. (2013). S110 Experience with suspected cancer referrals from the UK lung screen trial. Thorax. 68(Suppl 3). A57.3–A58. 1 indexed citations
13.
Nazareth, D., et al.. (2012). Fracture and Intra-Cardiac Embolisation of a Totally Implantable Vascular Access Device. Respiration. 83(6). 553–553. 1 indexed citations
14.
Shaw, Matthew, et al.. (2012). Impact of chronic obstructive pulmonary disease severity on surgical outcomes in patients undergoing non-emergent coronary artery bypass grafting. European Journal of Cardio-Thoracic Surgery. 42(1). 108–113. 66 indexed citations
15.
Hind, C R, et al.. (2003). Bronchoscopic insertion of Gianturco stents for the palliation of malignant lung disease: 10 year experience. Lung Cancer. 42(1). 113–117. 22 indexed citations
16.
Ledson, M.J., Zaroug Wahbi, Peter L. Harris, & M. Walshaw. (1999). A large pelvic arteriovenous malformation in an adult patient with cystic fibrosis. Postgraduate Medical Journal. 75(884). 353–355. 5 indexed citations
17.
Ledson, M.J., Malcolm Gallagher, & M. Walshaw. (1998). Chronic Burkholderia cepacia bronchiectasis in a non-cystic fibrosis individual. Thorax. 53(5). 430–432. 26 indexed citations
18.
Colloff, Matthew J., J G Ayres, F. Carswell, et al.. (1992). The control of allergens of dust mites and domestic pets: a position paper. Clinical & Experimental Allergy. 22(s2). 1–28. 254 indexed citations
19.
Walshaw, M., Rachel Lim, Christopher C. Evans, & C R Hind. (1988). Prescription of oxygen concentrators for long term oxygen treatment: reassessment in one district.. BMJ. 297(6655). 1030–1032. 33 indexed citations
20.
Walshaw, M. & C.C. Evans. (1986). Allergen Avoidance in House Dust Mite Sensitive Adult Asthma. QJM. 58(226). 199–215. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jordan N. Fink Breakdown of academic impact, for papers by Jim Mark Ingram Breakdown of academic impact, for papers by A J Woolcock Breakdown of academic impact, for papers by Hugo Van Bever Breakdown of academic impact, for papers by F. Brémont Breakdown of academic impact, for papers by L. G. Hansen Breakdown of academic impact, for papers by George W. Ward Breakdown of academic impact, for papers by Garrison H. Ayars Breakdown of academic impact, for papers by Paraskevi Xepapadaki Breakdown of academic impact, for papers by Marina Attanasi
Rankless by CCL
2026